Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
2.190
0.00 (0.00%)
At close: Oct 6, 2025, 4:00 PM EDT
2.200
+0.010 (0.46%)
Pre-market: Oct 7, 2025, 5:30 AM EDT

Jaguar Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
11.8111.699.7611.964.349.39
Upgrade
Revenue Growth (YoY)
15.96%19.75%-18.36%175.80%-53.81%62.51%
Upgrade
Cost of Revenue
2.141.962.042.022.333.16
Upgrade
Gross Profit
9.679.737.729.9426.22
Upgrade
Selling, General & Admin
26.9524.0223.0526.712620
Upgrade
Research & Development
15.5716.5418.617.6515.086.41
Upgrade
Operating Expenses
42.5240.5741.6444.3541.0826.41
Upgrade
Operating Income
-32.85-30.83-33.92-34.42-39.07-20.19
Upgrade
Interest Expense
--0.23-6.38-12.72-8.42-2.79
Upgrade
Interest & Investment Income
0.34-----
Upgrade
Other Non Operating Income (Expenses)
-7.09-9.43-4.930.93-2.72-2.51
Upgrade
EBT Excluding Unusual Items
-39.59-40.5-45.23-46.21-50.21-25.48
Upgrade
Asset Writedown
---0.37---0.12
Upgrade
Other Unusual Items
-1.821.253.7-2.19-2.39-8.21
Upgrade
Pretax Income
-41.41-39.25-41.9-48.4-52.6-33.81
Upgrade
Earnings From Continuing Operations
-41.41-39.25-41.9-48.4-52.6-33.81
Upgrade
Minority Interest in Earnings
0.770.760.60.940.01-
Upgrade
Net Income
-40.65-38.49-41.3-47.45-52.6-33.81
Upgrade
Preferred Dividends & Other Adjustments
-----4.84
Upgrade
Net Income to Common
-40.65-38.49-41.3-47.45-52.6-38.65
Upgrade
Shares Outstanding (Basic)
200---
Upgrade
Shares Outstanding (Diluted)
200---
Upgrade
Shares Change (YoY)
26.38%1809.95%----
Upgrade
EPS (Basic)
-26.56-130.69-2678.17---
Upgrade
EPS (Diluted)
-26.56-130.69-2678.17---
Upgrade
Free Cash Flow
-27.68-29.4-33.24-33.18-34.98-15.29
Upgrade
Free Cash Flow Per Share
-18.09-99.82-2155.63---
Upgrade
Gross Margin
81.88%83.28%79.13%83.11%46.18%66.31%
Upgrade
Operating Margin
-278.13%-263.76%-347.50%-287.85%-901.36%-215.09%
Upgrade
Profit Margin
-344.16%-329.30%-423.11%-396.91%-1213.26%-411.81%
Upgrade
Free Cash Flow Margin
-234.34%-251.52%-340.56%-277.53%-806.83%-162.87%
Upgrade
EBITDA
-30.94-28.93-31.91-32.43-37.36-18.46
Upgrade
EBITDA Margin
-261.96%-247.51%--271.28%--196.69%
Upgrade
D&A For EBITDA
1.911.92.011.981.721.73
Upgrade
EBIT
-32.85-30.83-33.92-34.42-39.07-20.19
Upgrade
EBIT Margin
-278.13%-263.76%--287.85%--215.09%
Upgrade
Revenue as Reported
11.8111.699.76-4.34-
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q